MASI

NASDAQ Healthcare

Masimo Corporation - Common Stock

Medical Devices

Masimo Corporation engages in the development, manufacture, and marketing of various patient monitoring technologies, and automation and connectivity solutions worldwide. It offers Masimo Signal Extraction Technology (SET) pulse oximetry with measure-through motion and low perfusion pulse oximetry monitoring to address the primary limitations of conventional pulse oximetry; Masimo Rainbow SET platform, including rainbow SET Pulse CO-Oximetry products that allows noninvasive monitoring of oxygen, carboxyhemoglobin, and methemoglobin. It also provides brain function and hemodynamic monitoring solutions; patient position and activity tracking, and neuromodulation technology solutions; and Masimo Hospital Automation platform, including hospital automation solutions, including Patient SafetyNet, Iris, iSirona, Replica, and UniView; and brain function monitoring, hemodynamic monitoring, regional oximetry, acoustic respiration rate monitoring, capnography and gas monitoring, and telehealth solutions. In addition, the company provides its products through direct sales force, distributors, and original equipment manufacturers partners to hospitals, emergency medical service and home care providers, long-term care facilities, physician offices, veterinarians, and consumers. Masimo Corporation was incorporated in 1989 and is headquartered in Irvine, California.

๐Ÿ“Š Market Data
Price$178.48
Volume1,008,437
Market Cap9.35B
Beta1.200
RSI (14-Day)50.5
200-Day MA$152.72
50-Day MA$177.21
52-Week High$179.00
52-Week Low$125.94
P/E Ratio46.48
Forward P/E27.04
Price / Book12.89
๐ŸŽฏ Investment Strategy Scores

MASI scores across each investment strategy. Higher is better for that strategy's goals.

High dividend yield + low volatility
๐Ÿš€ Moon Shot 72/100โ–ฒ +3
High growth potential (high beta + oversold)
๐Ÿ”ช Falling Knife 41/100โ–ฒ +4
Contrarian plays (oversold + below moving average)
๐ŸŽˆ Over-Hyped 36/100โ–ผ -5
Overbought stocks (potential short candidates)
Large-cap, institutional-quality stocks
๐Ÿ” Strategy Interpretation

Best fit: ๐Ÿš€ Moon Shot (72/100) โ€” this strategy High growth potential (high beta + oversold).

Lowest fit among scored strategies: ๐Ÿ’ฐ Dividend Daddy (20/100). No single score is a buy or sell signal โ€” use multiple lenses together. Learn how to read these scores โ†’

Find MASI in your text

Paste any article, transcript, or post โ€” the tool will extract MASI and every other hidden ticker.

Try the Ticker Extractor โ†’

Disclaimer: This data is for educational and entertainment purposes only and does not constitute financial advice. Market data may be delayed. Always do your own research before making investment decisions.
Data last updated: 2026-05-01.